Erik N Taylor Selected Research

Reperfusion Injury

1/2019

Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik N Taylor Research Topics

Disease

7	Infections 12/2015 - 01/2009
1	Thrombosis (Thrombus) 12/2022
1	Atherosclerosis 12/2022
1	Stroke (Strokes) 12/2022
1	Rupture 12/2022
1	Atherosclerotic Plaque (Atheroma) 12/2022
1	Myocardial Infarction 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 09/2022
1	Ovarian Epithelial Carcinoma 09/2022
1	Neoplasms (Cancer) 09/2022
1	Reperfusion Injury 01/2019
1	Ischemia 01/2019
1	Bacterial Infections (Bacterial Infection) 10/2012
1	Ventilator-Associated Pneumonia 01/2012

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 01/2012
1	CholesterolIBA 12/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 12/2022
1	LipidsIBA 12/2022
1	Phenobarbital (Luminal)FDA Link 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2022
1	LuciferasesIBA 09/2022
1	CalpainIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Cardiac MyosinsIBA 01/2019
1	Dental Implants (Dental Implant)IBA 12/2015
1	Lipid NanoparticlesIBA 01/2014
1	lauric acid (dodecanoic acid)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Nonesterified Fatty Acids (NEFA)IBA 01/2014
1	Oleic Acid (Oleate)IBA 01/2014
1	Vancomycin FDA LinkGeneric 10/2013
1	TitaniumIBA 07/2013
1	MetalsIBA 10/2012
1	SaltsIBA 10/2012
1	Biocompatible Materials (Biomaterials)IBA 01/2012

Therapy/Procedure

1	Immunotherapy 09/2022
1	Length of Stay 01/2014
1	Mechanical Ventilators (Ventilator) 01/2012
1	Operative Surgical Procedures 01/2009